JP2025506374A5 - - Google Patents
Info
- Publication number
- JP2025506374A5 JP2025506374A5 JP2024545861A JP2024545861A JP2025506374A5 JP 2025506374 A5 JP2025506374 A5 JP 2025506374A5 JP 2024545861 A JP2024545861 A JP 2024545861A JP 2024545861 A JP2024545861 A JP 2024545861A JP 2025506374 A5 JP2025506374 A5 JP 2025506374A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- amount
- crystalline form
- pharmaceutically acceptable
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263305631P | 2022-02-01 | 2022-02-01 | |
| US63/305,631 | 2022-02-01 | ||
| PCT/US2023/061651 WO2023150500A1 (en) | 2022-02-01 | 2023-01-31 | Peptide inhibitors of interleukin-23 receptor and pharmaceutical compositions thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506374A JP2025506374A (ja) | 2025-03-11 |
| JP2025506374A5 true JP2025506374A5 (https=) | 2026-02-26 |
Family
ID=85556753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024545861A Pending JP2025506374A (ja) | 2022-02-01 | 2023-01-31 | インターロイキン－２３受容体のペプチド阻害剤及びその医薬組成物 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP4472999A1 (https=) |
| JP (1) | JP2025506374A (https=) |
| KR (1) | KR20240137102A (https=) |
| CN (1) | CN118829647A (https=) |
| AU (1) | AU2023215245A1 (https=) |
| CA (1) | CA3250172A1 (https=) |
| CL (1) | CL2024002263A1 (https=) |
| IL (1) | IL314629A (https=) |
| MX (1) | MX2024009477A (https=) |
| PE (1) | PE20241895A1 (https=) |
| TW (1) | TW202342496A (https=) |
| UY (1) | UY40135A (https=) |
| WO (1) | WO2023150500A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL322423A (en) | 2023-01-31 | 2025-09-01 | Janssen Pharmaceutica Nv | Methods for preparing crystalline peptide inhibitors of the interleukin-23 receptor |
| WO2025062347A1 (en) * | 2023-09-21 | 2025-03-27 | Janssen Pharmaceutica Nv | Interleukin-23 receptor antagonist for use in the treatment of ulcerative colitis |
| WO2025151385A1 (en) * | 2024-01-08 | 2025-07-17 | Janssen Pharmaceutica Nv | Peptide inhibitors of interleukin-23 receptor and uses thereof |
| WO2025163534A1 (en) * | 2024-01-31 | 2025-08-07 | Janssen Pharmaceutica Nv | Crystal form of a peptide inhibitor of interleukin-23 receptor |
| WO2025243217A1 (en) * | 2024-05-22 | 2025-11-27 | Janssen Pharmaceutica Nv | Crystal forms of peptide molecules |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8946150B2 (en) | 2011-06-14 | 2015-02-03 | Medical Diagnostic Laboratories, LLC. | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| CA3167751A1 (en) | 2020-01-15 | 2021-07-22 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
-
2023
- 2023-01-31 IL IL314629A patent/IL314629A/en unknown
- 2023-01-31 TW TW112103335A patent/TW202342496A/zh unknown
- 2023-01-31 JP JP2024545861A patent/JP2025506374A/ja active Pending
- 2023-01-31 PE PE2024001727A patent/PE20241895A1/es unknown
- 2023-01-31 KR KR1020247029181A patent/KR20240137102A/ko active Pending
- 2023-01-31 CA CA3250172A patent/CA3250172A1/en active Pending
- 2023-01-31 CN CN202380019940.2A patent/CN118829647A/zh active Pending
- 2023-01-31 EP EP23710146.4A patent/EP4472999A1/en active Pending
- 2023-01-31 WO PCT/US2023/061651 patent/WO2023150500A1/en not_active Ceased
- 2023-01-31 AU AU2023215245A patent/AU2023215245A1/en active Pending
- 2023-02-01 UY UY0001040135A patent/UY40135A/es unknown
-
2024
- 2024-07-26 CL CL2024002263A patent/CL2024002263A1/es unknown
- 2024-07-31 MX MX2024009477A patent/MX2024009477A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025506374A5 (https=) | ||
| US8507527B2 (en) | Method for stabilizing anti-dementia drug | |
| CA2846510A1 (en) | Choline salt of an anti - inflammatory substituted cyclobutenedione compound | |
| JP2009537538A5 (https=) | ||
| EP2051694B1 (en) | Pharmaceutical compositions comprising aripiprazole | |
| KR20160101720A (ko) | Azd9291을 포함하는 제약 조성물 | |
| JP2020523335A5 (https=) | ||
| KR20180066039A (ko) | 아파티닙을 포함하는 약학적 조성물 | |
| JP2023536667A5 (https=) | ||
| KR101920996B1 (ko) | HMG-CoA 환원효소 저해제 및 칼슘채널 차단제를 포함하는 복합제제 | |
| US20040157925A1 (en) | Stable pharmaceutical composition of pravastatin | |
| KR20140140353A (ko) | 안정성 및 약물상호작용이 개선된 경구용 복합 정제 조성물 | |
| JP2018145095A (ja) | エルロチニブ塩酸塩含有医薬組成物 | |
| WO2018091609A1 (en) | Formulation comprising 4-methylpyrazole | |
| WO2015069203A1 (en) | Capsule comprising rupatadine fumarate and montelukast sodium | |
| JP2024525954A5 (https=) | ||
| KR101524264B1 (ko) | 발사르탄 함유 경구용 약학 조성물 | |
| US20150190388A1 (en) | Pharmaceutical composition of moxifloxacin hydrochloride and preparation method | |
| JP7423297B2 (ja) | 口腔内崩壊錠およびその製造方法 | |
| US20160015708A1 (en) | Stable dosage forms of imatinib mesylate | |
| RU2022102775A (ru) | Фармацевтический препарат | |
| EP3731931A2 (en) | Modified release formulations of fesoterodine | |
| EP4420658A1 (en) | A film coated tablet comprising empagliflozin | |
| US20240122857A1 (en) | Pharmaceutical formulations of indoleamine 2, 3-dioxygenase inhibitors | |
| RU2017123772A (ru) | Фармацевтическая композиция на основе N-бензил-N-метил-1-фенилпирроло [1,2-a] пиразин-3-карбоксамида |